Therapeutic target for pancreatic cancer cells
AssigneeThe Translational Genomics Research Institute
InventorsCliff Whatcott, Haiyong Han
Life of this patent
Estimating the term…
Abstract
This invention provides a therapeutic target for pancreatic cancer. The invention further provides methods of screening of new therapeutic agents using the target. The invention also provides a pharmaceutical composition comprising fasudil or derivatives thereof for pancreatic cancer treatment, and a kit comprising such a pharmaceutical composition.
Claims19
A method for identifying a treatment responding subgroup of subjects having pancreatic cancer, comprising:
- a. receiving a sample from a subject;
- b. detecting abnormality of ROCK1 gene represented by SEQ ID NO:
- 1 in the sample relative to the ROCK1 gene of a sample free of pancreatic cancer cell a sample having treatment non-responding pancreatic cancer;
- and
- c. identifying ROCK1 inhibitor sensitivity as being present in the subject providing the sample.
A method of inhibiting pancreatic tumor cell proliferation comprising the step of administering a pharmaceutical composition comprising fasudil or derivatives thereof to a subject in need thereof.
Dependencies are inferred from the claim text.